Perceptions, Myths & New Thinking on Direct-to-Patient Clinical Supply
January 23, 2020 | 11am ET / 8am PT | Catalent

This webinar reveals results from a recent industry survey that sought to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so. Register now to learn more.

Top health industry issues of 2020: Will digital start to show an ROI?
January 22, 2020 | 1pm ET / 10am PT | PwC

Each year, PwC's Health Research Institute (HRI) names the top issues for the health industry in the coming year. What made the list for 2020? Join HRI for a discussion of the most important trends for providers, insurers, pharma/life sciences and employers. Register now.

The Art of Recognizing Clinical Supply Risk Factors and Applying Proactive Measures Avoid Study Delays and Disruptions
January 14, 2020 | 1pm ET / 10am PT | Catalent

Are there certain types of clinical sponsors and studies that are at greater risk of experiencing supply challenges? This webinar will explore aspects of the study protocol that can directly influence clinical supply strategy and how sponsors can proactively understand and address clinical supply-related risks. Register now.

Artificial Intelligence in the Pharma Industry

Obtaining feedback from Life Sciences organizations are key in the delivery of actionable insights that our target customers come to expect. Our goal is to assess how far the adoption of AI technology has come in Life Sciences. Let your voice be heard in this survey.

How to Protect your Supply Chain from Security and Compliance Threats Utilizing On-Dose Authentication Technologies

In this whitepaper, we look at robust strategies that pharmaceutical manufacturers can adopt to protect their supply chain. Innovative solutions, such as on-dose microtags, are now being used to authenticate products; this mitigates counterfeiting, product diversion and helps to monitor returned product, quality control and recall. Download the whitepaper to learn more!

Transportation Solutions for Cell & Gene Therapy Supply Chains
December 17, 2019 | 11am ET / 8am PT | Thermo Fisher Scientific

From the basics such as service level expectations for couriers versus integrators, to how to evaluate domestic and international lanes, and finally – how to balance risk and cost, this webinar will help you understand how to start tackling your clinical supply chain. Register now.

The Unexpected Key to Building Value in Drug Discovery and Development

Drug development is an increasingly challenging industry with R&D returns declining, regulatory hurdles increasing, and the competition for funding ever fierce. Metabolomics is an essential technology for helping you overcome these challenges by bringing a focused approach to your data discovery while uncovering actionable insights. Read the whitepaper today!

Digital Medicine 101
December 12, 2019 | 12pm ET / 9am PT | Amazon Web Services

Join us as an interdisciplinary group of experts from the Digital Medicine Society (DiMe) provide a brief introduction to core concepts and terms that define digital medicine, along with practical tips for implementation and case examples. 

Medical Devices and Advanced Analytics: Delivering on the Promise of Connected Data
Recorded on December 11, 2019 | Medidata

Today, the rise of a new generation of robotic, precision, and surgical devices has created vast stores of video, imaging, and electronic surgical notes, prompting the question: How do you leverage these datasets and improve patient treatments and outcomes? Register now to learn how a connected data platform offers a definitive answer. 

Digital Twins: Creating Digital Operations Today to Deliver Business Value Tomorrow
This whitepaper highlights the challenges of implementing the right digital twin strategy while providing key use cases in the manufacturing domain for which a digital twin is extremely useful and several examples of technology trends that will shape the future. | Altran

This whitepaper highlights the challenges of implementing the right digital twin strategy while providing key use cases in the manufacturing domain for which a digital twin is extremely useful and several examples of technology trends that will shape the future. Download now.

Connecting Primary Container Systems with Excipient Evaluation During Drug Development
Recorded on December 5, 2019 | West Pharmaceutical Services, Inc.

Why should the primary container system be considered an excipient? Register for West’s webinar on December 5, to gain insight on considerations that should be made to mitigate packaging risks early in the drug development process! 

Planning a Rapid Commercial Market Launch for Your Biologic
Recorded on December 4, 2019 | Catalent

In this webinar, AstraZeneca and Catalent Biologics experts will share a case study on a 30-day commercial launch plan for a product into new markets and why this approach was important for patients. Register now.

How ICON, Lotus, and Bioforum are Improving Study Efficiency with a Modern EDC
Recorded on December 3, 2019 | Veeva

Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management.  Learn how to reap the rewards of a straightforward build and a modern EDC during this webinar. Register now.

Q2 2019 Life Sciences M&A notes and trends
Clarivate Analytics


Get your copy of the Q2 2019 Life Sciences M&A notes and trends. You’ll get insights like:

  • The top 11 M&A deals with values over $500 million
  • Oncology deals spend and breakdown
  • Why AbbVie led the M&A activity in the biopharmaceutical sector 
  • 5 year Allergan launch activity expected to close at the beginning of 2020
What You Need to Know to Avoid Costly Delays in Your API Scale-Up
Thermo Fisher Scientific

Drug developers must be prepared to react to changes in their API’s quality attributes, even if the synthesis used at a small scale is the same one used at a large scale. If undesirable effects occur that negatively impact API scale-up, it can prevent a company from delivering a product with reliable quality and efficacy. Click here to learn more!

The Impact of Step-Therapy Policies on Patients
Eli Lilly and Company in partnership with Xcenda

When payers insert themselves into the clinical decision-making process, it can diminish the trust and confidence patients have in their healthcare providers. Download this complimentary paper that explores the practice of step therapy and its impact on key stakeholders in the US healthcare system.

Paid Marketplace
[Q&A] Embarking Upon the Commercial Manufacturing Journey for a Biologic
Catalent Pharma Solutions

In this Q&A, four Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the success of a biologic when embarking upon the commercial manufacturing journey. Click here to learn more!

Prescription Drug Pricing: How Lack of Transparency Reduces Market Access, Utilization, and Adherence

It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers. Download this whitepaper now to learn more about prescription drug price transparency and its role in creating affordability, accessibility, and accountability.

Driving Patient Innovation Through Software as a Medical Device
Recorded on November 21, 2019 | Accenture

Accenture experts will explore the emergence of SaMD as a new class of medical device and discuss the potential challenges that biopharma companies face in the development of these solutions. Register for this webinar now.

Striving for Zero in Quality & Manufacturing
Recorded on November 19, 2019 | OpenText

Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. At the same time, they must meet GxP requirements, update antiquated systems and processes, and address the demands of an increasingly tech savvy workforce. Register now to learn more about the role that content management plays in pharmaceutical manufacturing.

Innovative Funding Models for Treatment of Cancer and Other High-Cost Chronic Noncommunicable Diseases
Roche and IQVIA

The global landscape study identifies and assesses innovative funding models for cancer and other high-cost chronic NCDs across Africa, Asia, Europe, Latin America and Middle East. The study aims to enable readers to better understand the possibilities that innovative funding models bring to bridge the current and future funding gap,while stressing the key success factors that enable sustainability and success such as stakeholder collaboration. Click here to download the whitepaper!

Research Operations for Secondary Use of Clinical Sites’ EMR
New Whitepaper | Evidera

The increasing global adoption of electronic medical records (EMRs) at clinical sites has prompted interest in using sites’ EMRs systematically for observational studies. Discover the benefits and challenges, both technical and operational, of implementing site-based EMR studies in this white paper.  Read now.

Modernizing clinical trials with Amazon Web Services (AWS)
Amazon Web Services

Managing the volume and variability of healthcare data is a challenge for many life sciences organizations looking to modernize clinical trials. From data management to IoT to high-performance computing and machine learning, life sciences organizations are working with Amazon Web Services (AWS) and AWS Partners to develop life science solutions that are scalable, global, and secure. Click here to download the eBook!

Tackling Clinical Trial Data Overload with Data Lakes and Machine Learning

This whitepaper explores how a data lake, enabled by AI and ML, can be used to ingest, aggregate, standardize and provide secured data access and the value it can deliver in reducing risk and driving efficiency, speed and cost savings. Download now.

Lipid-based Formulations for Early Stage Clinical Trials
November 13, 2019 | 10am ET / 7am PT | Lonza

Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic. Register now to learn more about lipid-based formulations.

OTC Innovation to Avoid Stagnation: Survey Insights, Expert Advice, and Latest Technologies to Boost Your Product’s Performance
November 13, 2019 | 11am ET / 8am PT | Catalent

Join industry experts as they analyze the critical role of innovation in OTC products, and strategies for achieving it. Register now to learn more about survey insights, market trends, and latest technologies.

The Promise of Connected Packaging—from Brand Protection to Consumer Insight
Recorded on November 12, 2019 | Systech

The transformations now taking place in the emerging field of connected packaging have the potential to address all these product challenges—protection, engagement, traceability—while delivering powerful supply chain insight. Register now to learn more.

Medical Affairs 2025 Excellence in the Era of Precision Medicine
Veeva Systems

Medical Affairs 2025 brings together leading perspectives from AstraZeneca, Bristol-Myers Squibb, Merck, Lilly, and other innovative life sciences organizations on key challenges impacting medical affairs and a roadmap for success in the coming decade.  Download the whitepaper.

Improving Diversity in Clinical Research
Recorded on November 6, 2019 | Rho

Why is diversity in clinical trials important? Minority populations are more likely to be diagnosed with certain cancers, stroke, diabetes, and are more likely to die prematurely than White Americans. Health disparities by race and ethnicity could increase if minority populations are not included in clinical trials. 

Register now to learn who is participating in clinical trials and why.

IBM Clinical Development: Key solutions for more efficient clinical research
IBM Watson Health

By collaborating with industry experts on advanced technologies, we find new ways to help clinicians improve patients’ lives. IBM’s highlighted solutions reside in a security-rich cloud environment—home for capturing, managing and analyzing clinical study data with control, accuracy and confidence. These solutions lay the groundwork for further integration with IBM® Watson® cognitive technology.

Unleash the Power of an Integrated Imaging and EDC Platform
November 5, 2019 | 11am ET / 8am PT | Medidata

Integrated Imaging and EDC ensures the right data is presented to the right users at the right time, free from manual intervention. Taking data reconciliation to a whole new level means your trial not only saves time, resources and cost, but also drastically reduces your clinical trial risk. Register now to learn more.

How Big is the US Market for Medical Devices and Technologies?
IBM Watson Health

Inpatient View and Outpatient View are powered by robust data assets and use sophisticated projection methodologies to help ensure accuracy of reporting. This white paper is designed to demonstrate the utility of using the MarketScan® Inpatient View and Outpatient View online tools to efficiently size a market for a medical device or technology.

The importance of early key opinion leader outreach in the biologics and biosimilars marketplace
IBM Watson Health

Acknowledging various stakeholder networks, as well as recognizing variances within the regulatory environment, can be essential for companies looking to uncover the right decision-makers in support of biologics or biosimilars.  Download the whitepaper to learn more.

Show Preview
Integrated Sterile Injectable Contract Development & Manufacturing
Emergent BioSolutions

Fully integrated CDMO for biologics bulk drug substance and sterile injectable drug products. Benefit from our turnkey upstream and downstream support for eukaryotic, microbial and viral expression as well as finished dose services.

  • Cell, Viral, and Microbial
  • Single-Use Platform (2L to 4000L Scale)
  • Process & Analytical Development
  • Parenteral Formulation Development
  • Fill/Finish Capabilities
    • Vials & Pre-Filled Syringes
    • Liquid & Lyophilized products

Read Our Latest Article

To learn more, visit us at CPhI WW, Stand 120A50 or contact us at [email protected]

Show Preview
Coffee and conversation with ANI Global Source at booth 121H63
ANI Global Source

When consistent supply for your patients is critical, you can rely on an ANI Global Source collaboration. ANI Global Source is a specialty CDMO supporting late stage development and commercial pharmaceutical manufacture of:

  • Oral dosage forms
  • Creams & Gels
  • Hormones
  • Potent compounds
  • Class II controlled substances

Manufacturing your product requires more than raw materials and established processes. At ANI Global Source, expertise, safety, reliability, and integrity are at the core of everything we produce. Visit us at booth 121H63 to learn more.

Utilizing a Technology-first Approach to Maximize Brand Value & Gain Competitive Advantage
Recorded on October 29, 2019 | SHYFT

In this webinar, we'll highlight some of these approaches and demonstrate how data and analytics can be used to gain a competitive advantage and create differentiation. Register now.

Show Preview
Connect with Baxter at CPhI Worldwide in Frankfurt
Baxter BioPharma Solutions

Formulation challenges. Clinical supply hurdles.  Lifecycle management. Risk mitigation. Patent expiry concerns. At BioPharma Solutions, a business unit of Baxter, we know the high-stakes challenges you face in today’s complex parenteral marketplace — and how the work we do is vital to the patients you serve.

If you have an injectable molecule and are looking for sterile contract manufacturing services, we invite you to stop by our stand at CPhI Worldwide in Frankfurt (Hall 12.1, Space F81) to meet with a representative and discuss how we can help you achieve your molecule’s full potential. Learn more.

Show Preview
BioVectra Inc. – Your North American CDMO Partner for Complex Synthetic Chemistry Challenges
BioVectra Inc.: Synthetic Chemistry | Microbial Fermentation | Biologics

We assists clients with small molecule cGMP projects from lab to multi-metric ton quantities. Our team provides phase appropriate route and process development solutions for short-term scale-up and long-term manufacturing challenges.

With vast experience in downstream purification techniques (chromatography, crystallization), we have completed 100+ chemical API projects (10 ongoing commercial products), including: complex multi-step synthesis, potent handling, and controlled substances. FDA & Health Canada inspected.

To meet our team at CPhI (booth 121H42), email [email protected]!

Enabling Formulations by Spray Drying: From Early Development to Commercialization
Recorded on October 24, 2019 | Patheon

Discover an approach to solubility and bioavailability enhancement of poorly water soluble drug molecules, approaches to aqueous-based spray drying of bio-pharmaceuticals as well as small molecules intended for inhalation delivery. Join us for this webinar to learn more.

Unlock Industry Perspectives on the Advantages and Challenges of Developing Advanced Dosage Forms
Recorded on October 22, 2019 | Catalent

Register for this webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations.

FiercePharma sits down with ZS Associates
ZS Associates

In this interview, Greg Fry, Patient and Consumer Analytics - ZS Associates, discusses consumer data and marketing trends and how to optimize digital campaigns. Watch the video.

Exploring What Physicians Know and Don’t Know About Nucleic Acid-Based Medicines
Recorded on October 16, 2019 | InCrowd
CIOs’ Perspectives: Driving Clinical Trial Innovation with a Unified Platform
Recorded on October 15, 2019 | Medidata

In this webinar, you will hear from Alan Louie, Ph.D, Research Director at IDC, Bill Swavely, CIO at Pharm-Olam, and Rama Kondru, Ph.D, CIO at Medidata about the need for a platform approach in clinical research, the rationale for switching from disparate systems to a unified platform, and the benefits that could be realized. Register now.

The Promise of Real-World Data: Using Technology to Enable the Standardization, Transparency, & Replicability of RWD Research
Recorded on October 10, 2019 | SHYFT Analytics

This webinar will address how the use of technology for deploying data and analytic standards can be utilized to meet the challenge of understanding and comparing findings between studies conducted by different researchers, by facilitating the standardization, transparency, reproducibility, and replicability of RWD research. Register now.

The Value of Real World Data in Orphan and 505(b)(2) Drug Development
Recorded on October 9, 2019 | Camargo

In this webinar, we'll share insights to harness the strategic value of real world data to build optimized drug development programs that minimize the time and cost of sponsor-driven studies. Register now!


Biosimilars and Drug Pricing
Recorded on October 3, 2019 | Elsevier

Join us for this webinar as we bring together a panel of industry experts to discuss the changing landscape of biosimilar development and how it will affect pricing in the future.

Synthetic Controls: Best Practices and Regulatory Perspectives
Recorded on October 2, 2019 | Medidata

With increasing competition for patients, the ability to effectively and efficiently execute on clinical development plans has increased focus on alternative data sources. In this one-hour session attendees will hear from former FDA leaders and industry experts who will address what Synthetic Control is and how it can be leveraged in clinical development.

Synthesizing Success: Six Principles for Getting Pharmaceutical Development Right from the Start
Patheon, by Thermo Fisher Scientific

As companies face pressure to bring drugs to market quicker & at minimal cost, pharma & biotech companies are outsourcing parts of drug development & manufacturing process. Outsourcing eliminates the need to maintain expensive in-house facilities & provides access to other technologies & expertise. Click here to download the whitepaper today!

Process Characterization: Ready For the FDA?
Recorded on October 1, 2019 | Thermo Fisher

Eight years after the FDA issued its guidance of process validation, some still ask the question “Is process characterization optional anymore?” This webinar will cover the basics of process characterization, whether it is optional or not, and what “good” process characterization really looks like. Register now!

Simplify and Accelerate Drug R&D With the MarkLogic Data Hub Service for Pharma R&D

In this industry, even small improvements to streamline R&D processes can lead to substantially higher revenue and lower costs. To achieve those goals, pharmaceutical companies need to leverage their massive data assets that include decades of research and clinical trial data. Download this whitepaper to learn more.

Effective Combination Products Risk Management Programs: Special Considerations for Control and Analytical Testing Strategies
Recorded on September 26, 2019 | West Pharma

Developing a combination product? Join experts Susan Neadle, Sr. Director, Global Value Chain Quality Design, Johnson & Johnson and Jennifer Riter, Sr. Director, Lab Services, West to learn how you can create an effective risk management program. Register Now!

Building the Digital Biotech Company
Recorded on September 25, 2019 | AWS and Moderna

Hear from Moderna’s Chief Digital and Operational Excellence Officer how they have eliminated data siloes to accelerate data-driven decisions at an enterprise level, and established a production environment capable of consistent delivery of complex drug products including a “batch of one”. Register Now!

How Patient Influencers are Driving Results for Pharma
WEGO Health

Patient influencers on social platforms like Facebook, Instagram and Twitter are driving high-value actions for brands, and pharma is no exception. Download our report to discover how influencers will help you boost brand trust and best practices for working with influencers.

De-Risking the Solid Form Landscape of an API
Recorded on September 19, 2019 | Cambrex

This presentation will discuss how predictable stability and solubility can minimize development timelines and cost. Attend to hear about two case studies exemplifying the importance of understanding the hydration space of an API and how hydrate formation may be avoided by development of a robust crystallization procedure.

Overcoming Challenges of Bioanalytical Method Development for Oligonucleotides and Large Molecules
Recorded on September 18, 2019 | CMIC

Please join the experts from CMIC Group, Japan’s largest CRO with over 30 years of analytical service experiences in US and Japan, to learn the insights and tips on developing an immunogenicity assay in a regulated laboratory, selecting a format for the neutralization assay for immunogenicity assessments, and quantitative Bioanalysis of Oligonucleotides by LC-MS. Register Now!

Flexible Manufacturing Strategies: What’s Best for Your Product?
Recorded on September 17, 2019 | Catalent

In this webinar, manufacturing experts will discuss the benefits of end-to-end solutions and share case studies on how flexible manufacturing strategies can accommodate the changing landscape of pharmaceutical products and help bring a drug to market. Register now!

Labs of the Future: Enabling Integrated Research Labs with Cloud Technology
Amazon Web Services

Download this whitepaper to learn how developing a digitized, integrated lab environment can facilitate collaborations and take advantage of technological advancements like machine learning to streamline and automate workflows- making research more productive.